Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients
Lei Wan,1 Liu-Jia-Zi Shao,1 Yang Liu,2 Hai-Xia Wang,1 Fu-Shan Xue,1 Ming Tian11Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of General Surgery, Beijing Friendship Hospital, Capital Medical University...
Main Authors: | Wan L, Shao LJZ, Liu Y, Wang HX, Xue FS, Tian M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/dexmedetomidine-reduces-sevoflurane-ec50-for-supraglottic-airway-devic-peer-reviewed-article-TCRM |
Similar Items
-
The optimum sevoflurane concentration for supraglottic airway device Blockbuster™ insertion with spontaneous breathing in obese patients: a prospective observational study
by: Haixia Wang, et al.
Published: (2017-11-01) -
Supraglottic airway devices in children
by: S Ramesh, et al.
Published: (2011-01-01) -
Supraglottic devices as alternative equipment to airway management in state of sudden cardiac arrest
by: Rafał Czyż, et al.
Published: (2017-08-01) -
Do the clinical parameters provide the reliable indication of airway findings in adult patients with acute supraglottitis?
by: Faraz Shafiq, et al.
Published: (2012-01-01) -
Sevoflurane sparing effect of dexmedetomidine in patients undergoing laparoscopic cholecystectomy: A randomized controlled trial
by: Preeti Sharma, et al.
Published: (2017-01-01)